Heart disease UPDATE | June 30 - July 7, 2016 | Public Health Genomics Knowledge Base (v1.0)

Public Health Genomics Knowledge Base (v1.0)



June 30 - July 7, 2016 


Last Updated: Jul 01, 2016

• IGNITE: Implementing Genomics in Practice
  Disease: Multiple Diseases; Type: Education|Tools; State: Multiple States
• Influence of VKORC1 and CYP2C9 Polymorphisms on Daily Acenocoumarol Dose Requirement in South Indian Patients With Mechanical Heart Valves.
  Kalpana S R, et al. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2016 6
• Apolipoprotein C3 gene variants and the risk of coronary heart disease: A meta-analysis.
  Li Yan, et al. Meta gene 2016 9 104-9
• The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy.
  Morales Ana et al. The Canadian journal of cardiology 2015 Nov (11) 1309-12
• Telomere length and health outcomes: A two-sample genetic instrumental variables analysis.
  Hamad Rita, et al. Experimental gerontology 2016 6 88-94
• Role of renal function in cardiovascular risk assessment: A retrospective cohort study in a population with low incidence of coronary heart disease.
  García-Gil Maria, et al. Preventive medicine 2016 6
• This Father's Day, Up Your Health Game 
• PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong.
  Wei Wei-Min, et al. Neurological research 2016 6 1-5
• Short Telomere Length and Ischemic Heart Disease: Observational and Genetic Studies in 290 022 Individuals.
  Scheller Madrid Alexander, et al. Clinical chemistry 2016 6
• Human genetic support for GLP1R agonism in diabetes…and heart disease?
  By Robert Plenge, Plenge Gen Blog, June 3, 2016
• A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
  Scott Robert A, et al. Science translational medicine 2016 6 (341) 341ra76
• The Role of Adiponectin in Coronary Heart Disease Risk: A Mendelian Randomization Study.
  Borges Maria Carolina, et al. Circulation research 2016 6
• The Correlation Between 9p21 Chromosome rs4977574 Polymorphism Genotypes and the Development of Coronary Artery Heart Disease.
  Tang Oushan, et al. Cardiovascular toxicology 2016 5
• [The possibility of selecting optimal antiplatelet therapy in patients with coronary heart disease in terms of CYP2C19 polymorphism].
  Bokeriya O L, et al. Terapevticheskii arkhiv 0 0 (5) 47-54
• PDE5A Polymorphisms Influence on Sildenafil Treatment Success.
  Marchal-Escalona Cristobal, et al. The journal of sexual medicine 2016 5

• CDC Information (18)
• CDC-Authored Pub (11)

• Human (50)
• Pathogen (1)

• Human (7193)
• Pathogen (0)

• Human (126)
• Pathogen (0)

• Guidelines (10)
• Tier Table (8)
• Synthesis (31)

• Implementation (110)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB